Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Phio: Starke Krebs-Daten befeuern Deal-Phantasie!
Phio: Starke Krebs-Daten befeuern Deal-Phantasie!

Phio Pharmaceuticals (WKN: A2PYB0) liefert neue positive Studiendaten zu seiner Immuntherapie-Plattform INTASYL. Die weit unter Buchwert handelnde Aktie schießt in die Höhe.

Wie Phio heute

1347 Property Insurance Holdings, Inc. Reports Fiscal Year 2019 Financial Results; Provides Updates on Business Strategy and Corporate Name Change
1347 Property Insurance Holdings, Inc. Reports Fiscal Year 2019 Financial Results; Provides Updates on Business Strategy and Corporate Name Change


1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”), a holding company which previously specialized in providing personal property insurance in coastal markets including those in

Mannatech Reports Fourth Quarter 2019 Financial Results
Mannatech Reports Fourth Quarter 2019 Financial Results


Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter of

Baidu Collaborates with Aardman to Promote “A Shaun the Sheep Movie: Farmageddon”
Baidu Collaborates with Aardman to Promote “A Shaun the Sheep Movie: Farmageddon”


Baidu, Inc. (Nasdaq: BIDU) and multi-award-winning animation studio, Aardman, have today announced a new collaboration to bring characters from Aardman’s newest feature film “A Shaun the Sheep

Baidu Collaborates with Aardman to Promote “A Shaun the Sheep Movie: Farmageddon”
Baidu Collaborates with Aardman to Promote “A Shaun the Sheep Movie: Farmageddon”


Baidu, Inc. (Nasdaq: BIDU) and multi-award-winning animation studio, Aardman, have today announced a new collaboration to bring characters from Aardman’s newest feature film “A Shaun the Sheep

Corona-Aktien kaufen: Heat Biologics ist Geschichte!
Corona-Aktien kaufen: Heat Biologics ist Geschichte!

Anfang des Monats berichteten wir über den ausgebrochenen Corona-Hype rund um Heat Biologics (WKN: A2JB4Y). Die Firma wurde auch in der Folgezeit nicht müde, die Krise für sich zu nutzen.

Satte 5

Azbil Launches Adjustable Proximity Sensor Featuring Two Outputs and Easy Installation
Azbil Launches Adjustable Proximity Sensor Featuring Two Outputs and Easy Installation


Azbil Corporation (TOKYO:6845) announced that it has launched the Adjustable Proximity Sensor Model H3C, which boasts two outputs and increased efficiency by allowing operators to check and

Azbil Launches Adjustable Proximity Sensor Featuring Two Outputs and Easy Installation
Azbil Launches Adjustable Proximity Sensor Featuring Two Outputs and Easy Installation


Azbil Corporation (TOKYO:6845) announced that it has launched the Adjustable Proximity Sensor Model H3C, which boasts two outputs and increased efficiency by allowing operators to check and

Azbil Launches Adjustable Proximity Sensor Featuring Two Outputs and Easy Installation
Azbil Launches Adjustable Proximity Sensor Featuring Two Outputs and Easy Installation


Azbil Corporation (TOKYO:6845) announced that it has launched the Adjustable Proximity Sensor Model H3C, which boasts two outputs and increased efficiency by allowing operators to check and

Granite REIT Declares Distribution for March 2020
Granite REIT Declares Distribution for March 2020


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CAD$0.242 per stapled unit for the month of

Novus Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results
Novus Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results


Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced financial

Granite REIT Notice of Conference Call for First Quarter 2020 Results
Granite REIT Notice of Conference Call for First Quarter 2020 Results


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) expects to announce its financial results for the first quarter ended March 31, 2020 after the close of markets on

Coventry Building Society Extends Relationship with GLORY
Coventry Building Society Extends Relationship with GLORY


GLORY today announced an extension of its relationship with Coventry Building Society, the second largest building society in the UK, with a further order for 40 Teller Cash Recyclers (TCRs).



In

Coventry Building Society Extends Relationship with GLORY
Coventry Building Society Extends Relationship with GLORY


GLORY today announced an extension of its relationship with Coventry Building Society, the second largest building society in the UK, with a further order for 40 Teller Cash Recyclers (TCRs).



In

Coventry Building Society Extends Relationship with GLORY
Coventry Building Society Extends Relationship with GLORY


GLORY today announced an extension of its relationship with Coventry Building Society, the second largest building society in the UK, with a further order for 40 Teller Cash Recyclers (TCRs).



In

Lysogene Announces the Date of Its 2020 General Shareholders’ Meeting and Amends Its Financial Calendar
Lysogene Announces the Date of Its 2020 General Shareholders’ Meeting and Amends Its Financial Calendar


Regulatory News:



Lysogene (FR0013233475 – LYS) (Paris:LYS) today announced the amendment of its corporate agenda* for 2020. The annual results for 2019 will be issued on 22 April 2020 instead of

Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan
Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan


Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan
Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan


Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan
Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan


Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan
Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan


Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan
Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan


Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an

Fuel Tech Reports 2019 Fourth Quarter and Full Year Financial Results
Fuel Tech Reports 2019 Fourth Quarter and Full Year Financial Results


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and

AYRO - Club Car Partnership Announce First Deliveries to Canada and Mexico
AYRO - Club Car Partnership Announce First Deliveries to Canada and Mexico


AYRO, Inc. (”AYRO” or the “Company”), a designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets

DIP wird Hilfszahlung für diejenigen anbieten, die über die Dienste von DIP in Teilzeit oder befristet beschäftigt sind, wenn sie aufgrund einer Coronavirus-bedingten Erkrankung arbeitsunfähig sind
DIP wird Hilfszahlung für diejenigen anbieten, die über die Dienste von DIP in Teilzeit oder befristet beschäftigt sind, wenn sie aufgrund einer Coronavirus-bedingten Erkrankung arbeitsunfähig sind


DIP Corporation (im Folgenden „DIP“ genannt), Hauptsitz: Minato-ku, Tokio, Japan; Präsident und CEO: Hideki Tomita gab am Montag, den 9. März, bekannt, dass das Unternehmen eine Hilfszahlung für

DIP Will Start Offering Relief Compensation to Those Who Are Employed in a Part-time or Contracted Capacity via DIP’s Services If They Are Unable to Work Due to a Coronavirus Related Illness
DIP Will Start Offering Relief Compensation to Those Who Are Employed in a Part-time or Contracted Capacity via DIP’s Services If They Are Unable to Work Due to a Coronavirus Related Illness


DIP Corporation (hereinafter “DIP”), Headquarters: Minato-ku, Tokyo, Japan; President and CEO: Hideki Tomita, announced on Monday, March 9 that it will start offering relief compensation to those